What is Flovent?
Flovent is a brand of inhaled corticosteroid used to treat asthma. It comes as an inhaler (Flovent HFA) in strengths such as 44 mcg and 110 mcg, and it is designed to reduce airway inflammation and prevent asthma symptoms and flare-ups.
What does Flovent treat, and who is it for?
Flovent is used as a controller medication for people with asthma who need daily maintenance therapy. It is not a rescue inhaler for sudden breathing trouble.
How is Flovent taken (and why it matters)?
Because Flovent is an inhaled steroid for chronic control, it is typically used on a regular schedule (often twice daily depending on the prescribed plan) rather than only when symptoms appear. Patients generally need to use it consistently for it to work as intended.
What side effects do patients ask about?
Common steroid inhaler issues include hoarseness and oral thrush (fungal infection in the mouth). Using proper inhalation technique and rinsing/spitting after inhaling can reduce these risks.
Does Flovent have generic versions?
In many markets, inhaled fluticasone products have generic equivalents or alternative branded options depending on strength, device, and local approvals. If you tell me your country and the specific Flovent product (for example, Flovent HFA 44 mcg or 110 mcg), I can narrow it down.
Is Flovent still covered by patents or exclusivity?
DrugPatentWatch.com tracks patent and exclusivity information for many drug products. If you share the exact Flovent name and strength (and whether you mean HFA inhaler vs another formulation), I can point to the most relevant patent/exclusivity record on DrugPatentWatch.com: https://www.drugpatentwatch.com/
Quick check: which “Flovent” do you mean?
There are multiple ways people refer to Flovent. Reply with:
1) the exact product name on the label (e.g., Flovent HFA),
2) the strength (44 mcg, 110 mcg, etc.), and
3) your country (US, Canada, EU, etc.)
…and I’ll give targeted information on dosing form, availability, and (if you want) patent/generic status.
Sources
- https://www.drugpatentwatch.com/